2020

There is no UHC without Universal Medicines Coverage

Europe Faces a Critical Time of Key Medicine Shortages Amidst a Pandemic

What do the next five years have in store for the European Medicines Agency?

Dutch institutions failing to register results of clinical trials

COVID-19 risks turning back the clock on years of essential development work

Barriers and facilitators of access to Internationally Controlled Essential Medicines in Kenya

Reflections on the World Health Assembly

COVID-19 And Its Far-Reaching Health Impacts in Sub-Saharan Africa

EU Must Not Miss its Chance on WHO Technology Pool

TRIPS-flexibilities in Health Crises and Beyond

Reversed gains in the advancement of SRHR in Kenya; effects of COVID-19

COVID-19, social determinants and frontline workers

Health Action International Working from Home

HAI Follows Dutch Government Advice in Response to COVID-19

2019

Halving snakebite deaths and disabilities by 2030 – How can we reach WHO’s goal?

A Momentous Week for Access to Medicines

Working together to end the suffering of pregnant women and families – Photo Essay

Staff Spotlight: Emma Shiffman

Civil Society Voice at International Summit to Tackle Global Health Challenge of Antimicrobial Resistance

Welcome to the new look website!

Dr Marg Ewen Receives the Helen Clark-JoPPP Award

Staff Spotlight: Jessica Davy

No Universal Health Coverage without Universal Medicines Coverage

2018

Our European Projects Highlights for 2018

A Year at the Heart of Regulatory Decision Making

HAI and Snakebite Programme Partner, James Ashe Antivenom Trust, Applaud Government Action on Antivenom at Bio-Ken Snakebite Symposium

Staff Spotlight: Sabrina Hennecke

Staff Spotlight: Jaume Vidal

Time for a Treaty? ReAct Reports on Second Consultation on Global Development & Stewardship Framework to Combat AMR

Medicijnen: de link met de maatschappij